In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $32.38 in the prior trading day, Akero Therapeutics Inc (NASDAQ: AKRO) closed at $30.97, down -4.35%. In other words, the price has decreased by -$4.35 from its previous closing price. On the day, 0.54 million shares were traded. AKRO stock price reached its highest trading level at $32.785 during the session, while it also had its lowest trading level at $30.95.
Ratios:
Our goal is to gain a better understanding of AKRO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.25 and its Current Ratio is at 17.25. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 06 ’24 when Yale Catriona sold 10,000 shares for $35.19 per share. The transaction valued at 351,890 led to the insider holds 74,158 shares of the business.
CATRIONA YALE bought 10,000 shares of AKRO for $327,400 on Nov 06 ’24. On Nov 01 ’24, another insider, Young Jonathan, who serves as the Chief Operating Officer of the company, sold 50,716 shares for $31.57 each. As a result, the insider received 1,601,252 and left with 216,286 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 2260097536 and an Enterprise Value of 1480791552.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $37.00, while it has fallen to a 52-week low of $13.47. The 50-Day Moving Average of the stock is 5.48%, while the 200-Day Moving Average is calculated to be 23.70%.
Shares Statistics:
The stock has traded on average 516.79K shares per day over the past 3-months and 689050 shares per day over the last 10 days, according to various share statistics. A total of 69.43M shares are outstanding, with a floating share count of 58.11M. Insiders hold about 16.30% of the company’s shares, while institutions hold 98.50% stake in the company. Shares short for AKRO as of 1730332800 were 3820964 with a Short Ratio of 7.39, compared to 1727654400 on 6766665. Therefore, it implies a Short% of Shares Outstanding of 3820964 and a Short% of Float of 5.6399997.
